[1]Zhai S, Tanimura A, Graves S M, et al. Striatal synapses, circuits, and Parkinson’s disease[J]. Curr Opin Neurobiol, 2017, 48: 9-16.
[2]Wang YL, Ju B, Zhang YZ, et al. Protective effect of curcumin against oxidative stress-induced injury in rats with Parkinson’s disease through the wnt/beta-catenin signaling pathway[J]. Cell Physiol Biochem, 2017, 43(6): 2226-2241.
[3]Kowal SL, Dall TM, Chakrabarti R, et al. The current and projected economic burden of Parkinson’s disease in the United States[J]. Mov Disord, 2013, 28(3): 311-318.
[4]Mccann H, Cartwright H, Halliday GM. Neuropathology of alpha-synuclein propagation and braak hypothesis[J]. Mov Disord, 2016, 31(2): 152-160.
[5]Liu X, Liu ZhY, Chen HJ, et al. Advances in relationship between gut microbiota and Parkinson’s disease[J]. Journal of Colorectal & Anal Surgery, 2020, 26(4): 410-413. (in Chinese)
刘欣, 刘忠于, 陈晖娟, 等. 肠道菌群与帕金森病相关性的研究进展[J]. 结直肠肛门外科, 2020, 26(4): 410-413.
[6]Ma Q, Li Y, Li P, et al. Research progress in the relationship between type 2 diabetes mellitus and intestinal flora[J]. Biomed Pharmacother, 2019, 117: 109138.
[7]Yang X, Liu L, Chen J, et al. Response of intestinal bacterial flora to the long-term feeding of aflatoxin B1 (AFB1) in mice[J]. Toxins (Basel), 2017, 9(10):317.
[8]Zhao YY, Fan XL, Wang XX, et al. Research progress on intestinal microbes and central nervous system diseases[J]. Journal of Practical Traditional Chinese Internal Medicine, 2020, 34(12):64-68. (in Chinese)
赵烊烊, 范兴丽, 王晓翔,等. 肠道菌群失调与中枢神经系统性疾病研究进展[J]. 实用中医内科杂志, 2020,34(12):64-68.
[9]Fang X. Microbial treatment: the potential application for Parkinson’s disease[J]. Neurol Sci, 2019, 40(1): 51-58.
[10]Holzer P, Farzi A. Neuropeptides and the microbiota-gut-brain axis[J]. Adv Exp Med Biol, 2014, 817: 195-219.
[11]Jing XL, Huo YB, Ren LM, et al. Protective effects of cerebroprotein hydrolysate for injection (Ⅰ) on vascular dementia in rats[J]. Drug Evaluation Research, 2017, 40(7):922-925. (in Chinese)
景小龙, 侯衍豹, 任雷鸣, 等. 注射用脑蛋白水解物(Ι)对血管性痴呆大鼠的保护作用[J]. 药物评价研究,2017, 40(7):922-925.
[12]Zhou T, Zhu M, Liang Z.(-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson’s disease[J]. Mol Med Rep, 2018, 17(4): 4883-4888.
[13]Caporaso JG, Lauber CL, Walters WA, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample[J]. Proc Natl Acad Sci USA, 2011, 108(Suppl 1): 4516-4522.
[14]Chen X, Sun H, Jiang F, et al. Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing[J]. Peer J, 2020, 8:e8317.
[15]Konya T, Koster B, Maughan H, et al. Associations between bacterial communities of house dust and infant gut[J]. Environ Res, 2014, 131: 25-30.
[16]Bedarf JR, Hildebrand F, Coelho LP, et al. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson’s disease patients[J]. Genome Med, 2017, 9(1): 39.
[17]Zhao F, Feng J, Li J, et al. Alterations of the gut microbiota in Hashimoto’s thyroiditis patients[J]. Thyroid, 2018, 28(2): 175-186.
[18]Zhao MQ, Mai YY, Lin BQ, et al. Neuroprotective effect of cerebrolysin in ophthalmology[J]. Chinese Journal of Biochemical and Pharmaceuticals, 2016, 36(12):196-199. (in Chinese)
赵明倩, 麦泳瑶, 林宝琴, 等. 脑蛋白水解物的视神经保护作用研究[J]. 中国生化药物杂志, 2016, 36(12): 196-199.
[19]Deng XJ, Huang XM, Zuo ChJ, et al. Research progress of cerebrolysin in the treatment of Alzheimer’s disease[J]. Chinese Journal of Biochemical and Pharmaceuticals, 2016, 36(11):200-204. (in Chinese)
邓湘俊, 黄夏梦, 左长京, 等. 脑蛋白水解物治疗阿尔茨海默病的研究进展[J]. 中国生化药物杂志, 2016, 36(11): 200-204.
[20]Sui R, Zang L, Bai Y. Administration of troxerutin and cerebroprotein hydrolysate injection alleviates cerebral ischemia/reperfusion injury by down-regulating caspase molecules[J]. Neuropsychiatr Dis Treat, 2019, 15: 2345-2352.
[21]Lü E, Fei XCh, Li K, et al. Effects of vasoactive intestinal peptide on synapse of MPTP-induced mice with Parkinson’s disease[J]. Acta Anatomica Sinica, 2018, 49(1):29-34. (in Chinese)
吕娥, 费学超, 李侃, 等. 血管活性肠肽对MPTP亚急性帕金森病模型小鼠突触的影响[J]. 解剖学报, 2018, 49(1): 29-34.
[22]Taylor TN, Greene JG, Miller GW. Behavioral phenotyping of mouse models of Parkinson’s disease[J]. Behav Brain Res, 2010, 211(1): 1-10.
[23]Winogrodzka A, Bergmans P, Booij J, et al. [(123)I]β-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson’s disease[J]. J Neurol Neurosurg Psychiatry, 2017, 74(3): 294-298.
[24]Becker A, Fassbender K, Oertel WH, et al. A punch in the gut-intestinal inflammation links environmental factors to neurodegeneration in Parkinson’s disease[J]. Parkinsonism Relat Disord, 2019, 60: 43-45.
[25]Zhu G, Jiang Y, Yao Y, et al. Ovotransferrin ameliorates the dysbiosis of immunomodulatory function and intestinal microbiota induced by cyclophosphamide[J]. Food Funct, 2019, 10(2): 1109-1122.
|